Takeda’s Board of Directors has unanimously appointed Julie Kim, currently the president of Takeda’s U.S. Business Unit, as the successor to Christophe Weber, Takeda’s current president, CEO and representative director. The move is effective when Weber retires from the company in June 2026. With three decades of experience in healthcare, Kim has held leadership positions at global, regional, country and functional levels. Her extensive background covers a range of therapeutic areas, internati...